Most notably, the U2 small nuclear ribonucleoprotein (snRNP) component SF3b1 has been found to be frequently mutated in blood cancers such as myelodysplastic syndromes (MDS). This evidence concerns the gene LSM2 and hematopoietic and lymphoid system neoplasm.